PHSRX Mutual Fund

NAV$58.57

Fund Essentials - as of Feb 28, 2026

Net Assets
-
Expense Ratio
1.29%
Dividend Yield (Current)
0.18%
Holdings
119
Inception Date
Jan 21, 2003
Fund Family
Putnam Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.85%
1 Year+21.24%
3 Year+8.72%
5 Year+8.32%
10 Year+10.14%

Asset Allocation

Stocks: 98.24%
Bonds: 0.15%
Other: 1.60%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company11.34%
JNJJOHNSON AND JOHNSON8.91%
ABBVAbbvie Inc Health Care5.94%
NOVN:SMNovartis Ag__05.53%
MRKMerck & Co. Inc.5.33%
Top 10 Concentration: 57.52%Report Date: Feb 28, 2026
Download all 119 holdings for PHSRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.18%
Frequency
Annually
Latest Distribution
$5.50
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how PHSRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$99/yr
7-day refund. Cancel anytime.
X-ray my whole portfolio
$99/yr Pro · 7-day refund. From MarketXLS, trusted since 2014.

PHSRX Mutual Fund Overview

PHSRX Mutual Fund (Putnam Global Health Care Fund Class R) is managed by Putnam Investments. PHSRX expense ratio is 1.29%, holding 119 positions across sectors including Health Care, Unknown, Other. Inception date: 2003-01-21.

PHSRX performance shows a YTD return of 3.85%. The 1-year return is 21.24% and the 5-year return is 8.32%. PHSRX dividend yield stands at 0.18%, paid annually.

PHSRX top holdings include Eli Lilly And Company (11.3%), JOHNSON AND JOHNSON (8.9%), Abbvie Inc Health Care (5.9%), Novartis Ag__0 (5.5%), Merck & Co. Inc. (5.3%). View all PHSRX holdings, sector breakdown, or dividend history.

PHSRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. PHSRX alternatives are available via the screener, along with tax-loss harvesting opportunities.